These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22850484)

  • 21. The mouse/human cross-species heterodimer of leucine-rich repeat kinase 2: possible significance in the transgenic model mouse of Parkinson's disease.
    Miyajima T; Ohta E; Kawada H; Maekawa T; Obata F
    Neurosci Lett; 2015 Feb; 588():142-6. PubMed ID: 25562633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models.
    Li T; Yang D; Zhong S; Thomas JM; Xue F; Liu J; Kong L; Voulalas P; Hassan HE; Park JS; MacKerell AD; Smith WW
    Hum Mol Genet; 2014 Dec; 23(23):6212-22. PubMed ID: 24993787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain.
    Simón-Sánchez J; Herranz-Pérez V; Olucha-Bordonau F; Pérez-Tur J
    Eur J Neurosci; 2006 Feb; 23(3):659-66. PubMed ID: 16487147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered Expression of
    Wu B; Xiao K; Zhang Z; Ma L
    Biomed Res Int; 2016; 2016():7681259. PubMed ID: 27872856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leucine-rich repeat kinase 2 is associated with the endoplasmic reticulum in dopaminergic neurons and accumulates in the core of Lewy bodies in Parkinson disease.
    Vitte J; Traver S; Maués De Paula A; Lesage S; Rovelli G; Corti O; Duyckaerts C; Brice A
    J Neuropathol Exp Neurol; 2010 Sep; 69(9):959-72. PubMed ID: 20720502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The parkinson's disease-associated LRRK2 mutation R1441G inhibits neuronal differentiation of neural stem cells.
    Bahnassawy L; Nicklas S; Palm T; Menzl I; Birzele F; Gillardon F; Schwamborn JC
    Stem Cells Dev; 2013 Sep; 22(18):2487-96. PubMed ID: 23600457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen.
    Maekawa T; Kubo M; Yokoyama I; Ohta E; Obata F
    Biochem Biophys Res Commun; 2010 Feb; 392(3):431-5. PubMed ID: 20079710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lrrk2 localization in the primate basal ganglia and thalamus: a light and electron microscopic analysis in monkeys.
    Lee H; Melrose HL; Yue M; Pare JF; Farrer MJ; Smith Y
    Exp Neurol; 2010 Aug; 224(2):438-47. PubMed ID: 20483355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.
    Li X; Tan YC; Poulose S; Olanow CW; Huang XY; Yue Z
    J Neurochem; 2007 Oct; 103(1):238-47. PubMed ID: 17623048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic and redundant regulation of LRRK2 and LRRK1 expression.
    Biskup S; Moore DJ; Rea A; Lorenz-Deperieux B; Coombes CE; Dawson VL; Dawson TM; West AB
    BMC Neurosci; 2007 Nov; 8():102. PubMed ID: 18045479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pivotal role of early B-cell factor 1 in development of striatonigral medium spiny neurons in the matrix compartment.
    Lobo MK; Yeh C; Yang XW
    J Neurosci Res; 2008 Aug; 86(10):2134-46. PubMed ID: 18338816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and pathological characterization of Lrrk2.
    Giasson BI; Covy JP; Bonini NM; Hurtig HI; Farrer MJ; Trojanowski JQ; Van Deerlin VM
    Ann Neurol; 2006 Feb; 59(2):315-22. PubMed ID: 16437584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity.
    Parisiadou L; Yu J; Sgobio C; Xie C; Liu G; Sun L; Gu XL; Lin X; Crowley NA; Lovinger DM; Cai H
    Nat Neurosci; 2014 Mar; 17(3):367-76. PubMed ID: 24464040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity.
    Heo HY; Park JM; Kim CH; Han BS; Kim KS; Seol W
    Exp Cell Res; 2010 Feb; 316(4):649-56. PubMed ID: 19769964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory.
    Beccano-Kelly DA; Volta M; Munsie LN; Paschall SA; Tatarnikov I; Co K; Chou P; Cao LP; Bergeron S; Mitchell E; Han H; Melrose HL; Tapia L; Raymond LA; Farrer MJ; Milnerwood AJ
    Hum Mol Genet; 2015 Mar; 24(5):1336-49. PubMed ID: 25343991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-γ induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages.
    Kuss M; Adamopoulou E; Kahle PJ
    J Neurochem; 2014 Jun; 129(6):980-7. PubMed ID: 24479685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal Cholinergic Interneurons Modulate Spike-Timing in Striosomes and Matrix by an Amphetamine-Sensitive Mechanism.
    Crittenden JR; Lacey CJ; Weng FJ; Garrison CE; Gibson DJ; Lin Y; Graybiel AM
    Front Neuroanat; 2017; 11():20. PubMed ID: 28377698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.
    West AB; Moore DJ; Choi C; Andrabi SA; Li X; Dikeman D; Biskup S; Zhang Z; Lim KL; Dawson VL; Dawson TM
    Hum Mol Genet; 2007 Jan; 16(2):223-32. PubMed ID: 17200152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging.
    Walker MD; Volta M; Cataldi S; Dinelle K; Beccano-Kelly D; Munsie L; Kornelsen R; Mah C; Chou P; Co K; Khinda J; Mroczek M; Bergeron S; Yu K; Cao LP; Funk N; Ott T; Galter D; Riess O; Biskup S; Milnerwood AJ; Stoessl AJ; Farrer MJ; Sossi V
    J Parkinsons Dis; 2014; 4(3):483-98. PubMed ID: 25000966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis.
    Rajput PS; Billova S; Patel SC; Kharmate G; Somvanshi RK; Kumar U
    J Chem Neuroanat; 2009 Sep; 38(1):20-33. PubMed ID: 19465111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.